News and commentary about white-collar crime, enforcement, and compliance
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
The Justice Department last week issued its first Foreign Corrupt Practices Act Opinion Procedure Release of the year. The Requestor in Release No. 09-01 is a medical device maker that wants to introduce its product to a foreign government.… Continue Reading
This week, Wright Medical Group became the latest orthopedic device maker to disclose a government investigation into its overseas sales practices. The company’s Form 8-K said its principal operating subsidiary, Wright Medical Technology, Inc.,… Continue Reading
It was just two weeks ago that we were waxing about the quiet times for FCPA watchers, due to the temporary bottleneck in the appointment of corporate monitors. But come to think of it, the Justice Department’s Fraud Section, the group in charge of FCPA enforcement, has a lot on its mind right now.… Continue Reading
It’s too soon to call it a pattern. But there’s something new in Foreign Corrupt Practices Act enforcement. During 2007, the U.S. ramped up two investigations that covered not just individual companies but entire industries.… Continue Reading
The Securities and Exchange Commission said in October this year it is investigating possible violations of the U.S. Foreign Corrupt Practices Act by the leading manufacturers of orthopedic implants. Biomet Inc.,… Continue Reading
The SEC’s just-announced investigation of several orthopedic device makers for possible violations of the U.S. Foreign Corrupt Practices Act (reported here) probably originated in February 2007. That’s when Johnson & Johnson said it had “voluntarily disclosed to the U.S.… Continue Reading
The Securities and Exchange Commission is investigating possible violations of the U.S. Foreign Corrupt Practices Act by Biomet Inc., Stryker Corp., Zimmer Holdings Inc., Smith & Nephew plc and Medtronic Inc.… Continue Reading